Testing new treatments to help manage epilepsy
SCREENING OF INVESTIGATIONAL THERAPEUTICS TO TREAT, MODIFY OR PREVENT EPILEPSY FOR THE NINDS EPILEPSY THERAPY SCREENING PROGRAM (ETSP)
['FUNDING_OTHER'] · UNIVERSITY OF UTAH · NIH-11250879
This study is looking at new treatments and devices to help people with epilepsy, especially those who have trouble with their current medications, to see if they can better control their seizures and improve their daily lives.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF UTAH (nih funded) |
| Locations | 1 site (SALT LAKE CITY, UNITED STATES) |
| Trial ID | NIH-11250879 on ClinicalTrials.gov |
What this research studies
This research focuses on evaluating new therapeutic agents and biomedical devices aimed at treating epilepsy and related disorders. It involves preclinical pharmacological evaluations of various investigational compounds, including small molecules and biologics, to determine their effectiveness in managing drug-resistant epilepsy and preventing the onset of seizures. The study will also explore models for disease prevention and modification, ensuring a comprehensive approach to epilepsy treatment. Patients may benefit from advancements in therapies that could lead to better seizure control and improved quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with drug-resistant epilepsy or those at risk of developing epilepsy.
Not a fit: Patients with well-controlled epilepsy or those who do not have epilepsy may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatments for epilepsy, potentially reducing the frequency and severity of seizures for patients.
How similar studies have performed: Previous research has shown promise in developing new therapies for epilepsy, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
SALT LAKE CITY, UNITED STATES
- UNIVERSITY OF UTAH — SALT LAKE CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WILCOX, KAREN — UNIVERSITY OF UTAH
- Study coordinator: WILCOX, KAREN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Disease, disease model, disease prevention, Disorder